Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.

VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.

Share this video  

Sleep Europe 2026 | Sleep and synaptic downscaling in levodopa-induced dyskinesia in Parkinson’s disease

Luigi Fiorillo, PhD, Neurocenter of Southern Switzerland (EOC), Lugano, Switzerland, discusses research showing that sleep-dependent synaptic downscaling is impaired in patients with Parkinson’s disease (PD) and levodopa-induced dyskinesia, unlike in healthy subjects or patients with PD without dyskinesia. Dr Fiorillo explains that high-density electroencephalography also showed persistently high theta activity, a marker of sleep pressure, suggesting that the normal build-up of sleep pressure during wake is also impaired. He also outlines ongoing work exploring whether acoustic stimulation could restore this process.
This interview took place at Sleep Europe 2026 in Maastricht, the Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

This is actually a super interesting project for me because at the moment this is the work I’m running in Lugano with Professor Galati. The focus is indeed in levodopa-induced dyskinesia, so we’re talking about Parkinson patients in an advanced state with hyperkinetic movements and what we are trying to, the phenomenon that we’re trying to study is not only about sleep, it’s also about wake...

This is actually a super interesting project for me because at the moment this is the work I’m running in Lugano with Professor Galati. The focus is indeed in levodopa-induced dyskinesia, so we’re talking about Parkinson patients in an advanced state with hyperkinetic movements and what we are trying to, the phenomenon that we’re trying to study is not only about sleep, it’s also about wake. So what I mean is that on these subjects what we have seen is that during sleep they have an impairment in what we call the synaptic downscaling process so we were measuring actually from an electrophysiological measure so the slow wave activity we were measuring indeed the slow wave activity in the late part of the night and the early part of the night. In healthy subjects you would see a difference between the, so a delta between the late and the early part of the night. In this Parkinson’s disease subgroup, so only levodopa-induced dyskinesia, not for the early Parkinson’s or advanced without dyskinesia, we did not see this pattern. So we actually can conclude somehow, there are a bunch of works out there, literature, saying that this synaptic depotentiation, downscaling procedure is impaired. This is about sleep. But then with this work, we were trying also to question, I mean, the next question, our next session was, what about during the morning? So if we check the sleep pressure of these patients in the morning, what would you find? And to characterize the sleep pressure, we have used here some recordings, high-density EEG recordings, 64 channels. So resting states, eyes closed, recorded in the morning to characterize the theta activity. And the theta activity, that is an electrophysiological marker of the sleep pressure were super high let’s say in this group compared to all the others and even more interesting was that the theta activity was high but was still high also in the evening so we did another recording with the same setting. And this was not the case, of course, in the healthy group, because in the healthy group, the theta activity, the sleep pressure, was lower. And we experienced this build-up process, so theta that accumulates over the day. So if you compute the difference in that case, you will see a positive difference, something that you will not see in our subgroup of levodopa-induced dyskinesia. So to summarize, actually both the sleep and wake downscaling and build-up process were impaired. And so let’s say that the last step, at least the project we are currently running, is trying to understand if we can, via the acoustic stimulation procedure, restore the downscaling procedure, the downscaling process, this impaired downscaling process in our dyskinetic subgroup and see if somehow we see also a sort of cause-effect. So better sleep, maybe during the wake part you will experience a less number of dyskinetic events.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.